Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oriel Therapeutics has announced that the US Patent and Trademark Office has issued a patent for dry powder dose filling systems and methods.
Subscribe to our email newsletter
The invention addresses the field of dry powder inhalers, and more specifically the drug containment systems (DCS) necessary for containment, protection and delivery of dry powder medicaments.
Materials, geometries and methods which facilitate the efficient and consistent delivery are described. Among these are features for assuring a sufficient level of DCS rigidity, and for allowing the use of integral vibratory elements for active dispersion of powder, the company said.
Paul Atkins, president and COO of Oriel, said: “This patent is part of an expanding portfolio that provides a strong intellectual property position for our range of delivery devices and their corresponding drug products.”